date,title,source
Oct-25-18,Presentations at ASN Kidney Week 2018 Highlight ChemoCentryx Platform in Treatment of ANCA-Associated Vasculitis and Focal Segmental Glomerulosclerosis (FSGS),GlobeNewswire
Oct-30-18,Earnings Preview: ChemoCentryx (CCXI) Q3 Earnings Expected to Decline,Zacks
Nov-01-18,"ChemoCentryx to Hold Third Quarter 2018 Financial Results Conference Call on Thursday, November 8, 2018",GlobeNewswire
Nov-08-18,"ChemoCentryx (CCXI) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-08-18,ChemoCentryx: 3Q Earnings Snapshot,Associated Press
Nov-08-18,ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights,GlobeNewswire
Nov-09-18,Edited Transcript of CCXI earnings conference call or presentation 8-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-20-18,ChemoCentryx to Present at the 30th Annual Piper Jaffray Healthcare Conference,GlobeNewswire
Nov-27-18,"New Research Coverage Highlights Ralph Lauren, CECO Environmental, PRA Group, ChemoCentryx, SunCoke Energy Partners, and Delek US  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-29-18,ChemoCentryxs Novel Small Molecule Antagonists of Checkpoint Inhibitors and Chemokine Receptors to be Presented at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy Conference,GlobeNewswire
Jan-02-19,ChemoCentryx to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Feb-20-19,ChemoCentryx to Present at the 8th Annual SVB Leerink Global Healthcare Conference,GlobeNewswire
Feb-26-19,"New Research: Key Drivers of Growth for Ellie Mae, Spotify Technology SA, Bristow Group, Teradata, ChemoCentryx, and AgroFresh Solutions  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
